Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Terence P. Rooney
Based on 21 articles published since 2009
(Why 21 articles?)
||||
Expertise Level
The expertise of Terence P. Rooney ranks in the
  • Top 0.76%
  • ... of 82,356 published authors worldwide on Rheumatoid Arthritis
  • ... from 2009 through 2019
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Rooney, Terence   ·   Rooney, Terence P
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2018
  • Botnar Research Centre, Nuffield Department ofOrthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. · Center for Rheumatology, Albany Medical College, Albany, New York, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. · Eli Lilly and Company, Indianapolis, Indiana, USA. · IQVIA, Morrisville, North Carolina, USA. · Laboratory Corporation of America Holdings (LabCorp), Morrisville, North Carolina, USA. · Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. · Pubmed 29463520
  • a First Department of Internal Medicine, School of Medicine , University of Occupational and Environmental Health , Kitakyushu , Japan. · b Division of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine , Hokkaido University , Hokkaido , Japan. · c Department of Rheumatology and Clinical Immunology , Saitama Medical Center, Saitama Medical University , Kawagoe , Japan. · d Department of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology , Tokyo Women's Medical University , Tokyo , Japan. · e Eli Lilly Japan K.K. , Kobe , Japan. · f Eli Lilly and Company , Indianapolis , IN , USA. · g Division of Rheumatology, Department of Internal Medicine , Keio University School of Medicine , Tokyo , Japan. · Pubmed 29134891
  • University of Occupational and Environmental Health Japan, Kitakyushu, Japan. · University of Glasgow, Glasgow, UK. · Botnar Research Centre and University of Oxford, Oxford, UK. · Eli Lilly and Company, Indianapolis, Indiana. · NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, and University of Leeds, Leeds, UK. · Pubmed 30058112
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA. · Center for Rheumatology, Albany Medical College, Albany, NY. · Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. · Latin Clinical Trial Center, San Juan, Puerto Rico. · Rheumatology, Hospital Infanta Luisa, Sevilla, Spain. · Department of Rheumatology and Clinical Immunology, University Hospital of Würzburg, Würzburg, Germany. · Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria. · Pubmed 29415145
  • a First Department of Internal Medicine, School of Medicine , University of Occupational and Environmental Health , Kitakyushu , Japan. · b Medicines Development Unit Japan , Eli Lilly Japan K.K , Kobe , Japan. · c Eli Lilly and Company , Indianapolis , IN , USA. · Pubmed 28440680
2017
  • Evidera, Inc, 1417 4th Avenue, Suite 510, Seattle, WA, 98101, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Evidera, Inc, Bethesda, MD, USA. · Pubmed 29212515
  • Evidera, Inc., 1417 4th Avenue, Suite 510, Seattle, WA, 98101, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Evidera Inc., Bethesda, MD, USA. · Pubmed 29208004
  • University of Colorado School of Medicine, Denver, CO, 80045, USA. · Keio University, Tokyo, Japan. · Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, 75231, USA. · Eli Lilly and Company, Indianapolis, IN, 46285, USA. · Eli Lilly and Company, Seoul, Republic of Korea. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Rheumatology, Brussels, Belgium. · McMaster University, Hamilton, ON, Canada. · CER, San Juan, Argentina. · Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Pubmed 28923098
  • Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28891251
  • The Rebecca MacDonald Centre for Arthritis, Mt. Sinai Hospital, Toronto, Canada. · Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · University of Occupational and Environmental Health, Fukuoka, Japan. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Medica Pro Familia, Warsaw, Poland. · Instituto Médico CER, Buenos Aires, Argentina. · Unidad Reumatologica Las Americas S.C.P. Médico, Mexico, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 28798049
  • From the Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences and the Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom (P.C.T.) · the Rebecca MacDonald Centre, Mount Sinai Hospital, University of Toronto, Toronto (E.C.K.) · Leiden University Medical Center, Leiden, the Netherlands (D.H.) · Brigham and Women's Hospital, Boston (M.E.W.) · Instituto Reumatológico Strusberg, Córdoba, Argentina (L.C.M.) · Centro de Investigacion Clinica Especializada, Mexico City (J.R.G.) · Ryazan Regional Clinical Cardiology Dispensary, Ryazan, Russia (S.Y.) · Eli Lilly, Indianapolis (T.I., S. Beattie, V.A., C.G., T.R., D.S., W.L.M., S. de Bono) · and AstraZeneca K.K., Osaka (K.E.), and the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu (Y.T.) - both in Japan. · Pubmed 28199814
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Albany Medical College, Albany, New York, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of New South Wales, Sydney, New South Wales, Australia. · Divisions of Rheumatology, Ophthalmology and Immunology, Valme University Hospital, Sevilla, Spain. · Stanford University Medical Center, Palo Alto, California, USA. · Lapeyronie Hospital, Montpellier University, Montpellier, France. · Pubmed 27799159
  • Metroplex Clinical Research Center, Dallas, Texas. · University of Colorado, Denver. · Leiden University Medical Center, Leiden, The Netherlands, and Imaging Rheumatology BV, Meerssen, The Netherlands. · Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico. · Centro Medico Privado de Reumatologia, Tucuman, Argentina. · Scientific Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Eli Lilly and Company, Indianapolis, Indiana. · Keio University School of Medicine, Tokyo, Japan. · Pubmed 27723271
  • Department of Rheumatology, Paris Descartes University, Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, INSERM (U1151), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France. · Leiden University Medical Center, Leiden, The Netherlands. · Division of Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan; Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan. · Desert Medical Advances, Palm Desert, California, USA. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, University of Leeds, Leeds, UK. · Pubmed 27689735
2016
  • From the Stanford University Medical Center, Palo Alto, CA (M.C.G.) · Albany Medical College, Albany, NY ( J.K.) · Rheumazentrum Favoriten (O.Z.) and the Medical University of Vienna ( J.S.S.) - both in Vienna · East Penn Rheumatology, Bethlehem, PA (C.L.) · Rheumatology Clinic, MAK-MED, Nadarzyn, Poland (M.K.) · and Eli Lilly, Indianapolis (L.X., S.D.B., A.E.K., T.E.C., T.P.R., W.L.M., S.B., D.E.S.). · Pubmed 27028914
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
2015
  • The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada. · Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Incyte Corporation, Wilmington, Delaware, USA. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 25431052
Probable:    University of Occupational and Environmental Health      
2016
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
Probable:    University of Tokyo      
2016
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Terence P. Rooney about Rheumatoid Arthritis:

  • Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies. 2018
  • Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials. 2018
  • Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis. 2018
  • Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis. 2018
  • Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study. 2018
  • Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis. 2017
  • Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis. 2017
  • Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. 2017
  • Dose/Exposure-Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis. 2017
  • Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. 2017
Show List of Full Article Records
Google Searches

Learn more about Terence P. Rooney using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
University of Occupational and Environmental Health
University of Tokyo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2018
  • Botnar Research Centre, Nuffield Department ofOrthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. · Center for Rheumatology, Albany Medical College, Albany, New York, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. · Eli Lilly and Company, Indianapolis, Indiana, USA. · IQVIA, Morrisville, North Carolina, USA. · Laboratory Corporation of America Holdings (LabCorp), Morrisville, North Carolina, USA. · Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. · Pubmed 29463520
  • a First Department of Internal Medicine, School of Medicine , University of Occupational and Environmental Health , Kitakyushu , Japan. · b Division of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine , Hokkaido University , Hokkaido , Japan. · c Department of Rheumatology and Clinical Immunology , Saitama Medical Center, Saitama Medical University , Kawagoe , Japan. · d Department of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology , Tokyo Women's Medical University , Tokyo , Japan. · e Eli Lilly Japan K.K. , Kobe , Japan. · f Eli Lilly and Company , Indianapolis , IN , USA. · g Division of Rheumatology, Department of Internal Medicine , Keio University School of Medicine , Tokyo , Japan. · Pubmed 29134891
  • University of Occupational and Environmental Health Japan, Kitakyushu, Japan. · University of Glasgow, Glasgow, UK. · Botnar Research Centre and University of Oxford, Oxford, UK. · Eli Lilly and Company, Indianapolis, Indiana. · NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, and University of Leeds, Leeds, UK. · Pubmed 30058112
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA. · Center for Rheumatology, Albany Medical College, Albany, NY. · Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. · Latin Clinical Trial Center, San Juan, Puerto Rico. · Rheumatology, Hospital Infanta Luisa, Sevilla, Spain. · Department of Rheumatology and Clinical Immunology, University Hospital of Würzburg, Würzburg, Germany. · Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria. · Pubmed 29415145
  • a First Department of Internal Medicine, School of Medicine , University of Occupational and Environmental Health , Kitakyushu , Japan. · b Medicines Development Unit Japan , Eli Lilly Japan K.K , Kobe , Japan. · c Eli Lilly and Company , Indianapolis , IN , USA. · Pubmed 28440680
2017
  • Evidera, Inc, 1417 4th Avenue, Suite 510, Seattle, WA, 98101, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Evidera, Inc, Bethesda, MD, USA. · Pubmed 29212515
  • Evidera, Inc., 1417 4th Avenue, Suite 510, Seattle, WA, 98101, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Evidera Inc., Bethesda, MD, USA. · Pubmed 29208004
  • University of Colorado School of Medicine, Denver, CO, 80045, USA. · Keio University, Tokyo, Japan. · Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, 75231, USA. · Eli Lilly and Company, Indianapolis, IN, 46285, USA. · Eli Lilly and Company, Seoul, Republic of Korea. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Rheumatology, Brussels, Belgium. · McMaster University, Hamilton, ON, Canada. · CER, San Juan, Argentina. · Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Pubmed 28923098
  • Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28891251
  • The Rebecca MacDonald Centre for Arthritis, Mt. Sinai Hospital, Toronto, Canada. · Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · University of Occupational and Environmental Health, Fukuoka, Japan. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Medica Pro Familia, Warsaw, Poland. · Instituto Médico CER, Buenos Aires, Argentina. · Unidad Reumatologica Las Americas S.C.P. Médico, Mexico, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 28798049
  • From the Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences and the Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom (P.C.T.) · the Rebecca MacDonald Centre, Mount Sinai Hospital, University of Toronto, Toronto (E.C.K.) · Leiden University Medical Center, Leiden, the Netherlands (D.H.) · Brigham and Women's Hospital, Boston (M.E.W.) · Instituto Reumatológico Strusberg, Córdoba, Argentina (L.C.M.) · Centro de Investigacion Clinica Especializada, Mexico City (J.R.G.) · Ryazan Regional Clinical Cardiology Dispensary, Ryazan, Russia (S.Y.) · Eli Lilly, Indianapolis (T.I., S. Beattie, V.A., C.G., T.R., D.S., W.L.M., S. de Bono) · and AstraZeneca K.K., Osaka (K.E.), and the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu (Y.T.) - both in Japan. · Pubmed 28199814
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Albany Medical College, Albany, New York, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of New South Wales, Sydney, New South Wales, Australia. · Divisions of Rheumatology, Ophthalmology and Immunology, Valme University Hospital, Sevilla, Spain. · Stanford University Medical Center, Palo Alto, California, USA. · Lapeyronie Hospital, Montpellier University, Montpellier, France. · Pubmed 27799159
  • Metroplex Clinical Research Center, Dallas, Texas. · University of Colorado, Denver. · Leiden University Medical Center, Leiden, The Netherlands, and Imaging Rheumatology BV, Meerssen, The Netherlands. · Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico. · Centro Medico Privado de Reumatologia, Tucuman, Argentina. · Scientific Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Eli Lilly and Company, Indianapolis, Indiana. · Keio University School of Medicine, Tokyo, Japan. · Pubmed 27723271
  • Department of Rheumatology, Paris Descartes University, Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, INSERM (U1151), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France. · Leiden University Medical Center, Leiden, The Netherlands. · Division of Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan; Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan. · Desert Medical Advances, Palm Desert, California, USA. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, University of Leeds, Leeds, UK. · Pubmed 27689735
2016
  • From the Stanford University Medical Center, Palo Alto, CA (M.C.G.) · Albany Medical College, Albany, NY ( J.K.) · Rheumazentrum Favoriten (O.Z.) and the Medical University of Vienna ( J.S.S.) - both in Vienna · East Penn Rheumatology, Bethlehem, PA (C.L.) · Rheumatology Clinic, MAK-MED, Nadarzyn, Poland (M.K.) · and Eli Lilly, Indianapolis (L.X., S.D.B., A.E.K., T.E.C., T.P.R., W.L.M., S.B., D.E.S.). · Pubmed 27028914
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
2015
  • The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada. · Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Incyte Corporation, Wilmington, Delaware, USA. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 25431052
University of Occupational and Environmental Health
2016
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
University of Tokyo
2016
  • From the First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; Eli Lilly and Co., Tokyo; Eli Lilly Japan K.K., Kobe, Japan; Eli Lilly and Co., Indianapolis, Indiana, USA.Sponsored by Eli Lilly Japan K.K. and Eli Lilly and Co., manufacturer/licensee of baricitinib. Eli Lilly Japan K.K. and Eli Lilly and Co. were involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Janelle Keys, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe, part of the Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2). ZC and TA are employees of Eli Lilly Japan K.K. KE, DS, TR, and WM are employees of Eli Lilly and Co. and KE owns stock in the company.Y. Tanaka, MD, PhD, Professor, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health; K. Emoto, MD, PhD, Medical Advisor, Eli Lilly and Co.; Z. Cai, PhD, Senior Associate, Eli Lilly Japan K.K.; T. Aoki, PhD, Senior Associate, Eli Lilly Japan K.K.; D. Schlichting, RN, MS, Principal Research Scientist, Eli Lilly and Co.; T. Rooney, MD, Medical Director, Eli Lilly and Co.; W. Macias, MD, PhD, Distinguished Medical Fellow, Eli Lilly and Co. · Pubmed 26834213
Veterans Health System
2011
  • Division of Rheumatology, VA Medical Center, University of California, San Francisco, CA, USA. · Pubmed 21441551
University of California San Francisco
2011
  • Division of Rheumatology, VA Medical Center, University of California, San Francisco, CA, USA. · Pubmed 21441551
University College Dublin
2010
  • Department of Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland. · Pubmed 19847430
  • Department of Rheumatology, St Vincent's University Hospital, Dublin 4, Ireland. · Pubmed 19460761
2009
Yearly article counts 05921000121
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.